(lp0
S"Catalyst Biosciences Inc.  Is Soaring After South Korean Approval RTT News - 18 hours ago Catalyst Biosciences Inc.  announced Tuesday morning that the Korean Ministry of Food and Drug Safety has approved its Investigational New Drug Application for CB 2679d/ISU304.Tuesday's Market Insights: Catalyst Biosciences Inc , Ocean Rig UDW Inc ... - Smarter AnalystWhy Catalyst Biosciences Inc  Stock Tripled on Tuesday - Investorplace.com"
p1
aS'BUZZ-US STOCKS ON THE MOVE-Darden Restaurants, Catalyst Biosciences, Tesla and ... Nasdaq - 17 hours ago PG.O&gt;: ** Catalyst Biosciences &lt;CBIO.O&gt;, up 208.7 pct at $15.90 [nFWN1H50H3] ** Akers Biosciences &lt;AKER.O&gt;, up 63.9 pct at $2.30 [nFWN1H50AU] ** ICC Holdings Inc &lt;ICCH.O&gt;, up 59.9 pct at $15.99 The top three percentage losers on the Nasdaq &lt;.'
p2
aS'Catalyst Biosciences Completes Merger With Targacept and Creates a Protease ... GlobeNewswire  - Aug 20, 2015 SOUTH SAN FRANCISCO, Calif., Aug. 20, 2015  -- Catalyst Biosciences, Inc. , a clinical-stage biopharmaceutical company focused on creating and developing novel medicines to address serious medical conditions,&nbsp;...Targacept sale to Catalyst is complete - Winston-Salem Journal'
p3
aS'Catalyst Biosciences reports 4Q loss Yahoo Finance - Mar 8, 2017  _ Catalyst Biosciences Inc.  on Wednesday reported a loss of $3.7 million in its fourth quarter. The South San Francisco, California-based company said it had a loss of $4.68 per share.Catalyst Biosciences Reports Fourth Quarter and Full Year 2016 Financial ... - GlobeNewswire The Brokerages Set $29.99 Target Price for Catalyst Biosciences Inc  - DailyQuint'
p4
aS'Catalyst Biosciences Inc. MarketWatch - Dec 14, 2013 Catalyst Biosciences Inc. NASDAQ: CBIO. GO. Set Alerts &middot; Find a Broker &middot; Join TD Ameritrade &middot; Market Index &middot; Overview Profile News Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders.'
p5
aS'Catalyst Biosciences Inc. CBIO  Wall Street Journal - Aug 7, 2011 News Catalyst Biosciences Inc.CBIO. Significant News Only. 03/08/17; Press Release. Catalyst Biosciences Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update.'
p6
aS'Catalyst Biosciences ending future research, eliminating half of workforce Winston-Salem Journal - Sep 7, 2016 The biopharmaceutical company that holds the remaining cash of defunct Targacept Inc. said Wednesday it is foregoing future research to focus on two drugs in its development pipeline.'
p7
aS"Current Movers: Micron Technology, Inc. , Catalyst Biosciences, Inc ... TopChronicle - 16 hours ago Micron Technology, Inc.  is currently trading with the volume of 11.67 Million. The Stock opened today's session at $28.73 and currently the price is hovering at $28.77 by showing increase of 0.03 percent."
p8
aS'Catalyst Biosciences  Enters Agreement with Wyeth StreetInsider.com - Dec 14, 2016 On December 8, 2016, Catalyst Biosciences, Inc.  entered into a definitive agreement  with Wyeth LLC, a wholly-owned subsidiary of Pfizer Inc.  following the June 1, 2015 termination of the research and license&nbsp;...'
p9
aS"Stock Update : Here's Why Catalyst Biosciences Inc Is ... Smarter Analyst - Dec 15, 2016 On December 8, 2016, Catalyst Biosciences Inc  entered into a definitive agreement with Wyeth LLC, a wholly-owned subsidiary of Pfizer Inc. following the June 1, 2015 termination of the research and license agreement that was entered into&nbsp;...Revenue Estimates Analysis: Catalyst Biosciences, Inc.  - News OracleUnusual 11 Mid-Day Movers 12/15:    Higher;  (PIR ... - StreetInsider.com"
p10
a.